The generation of layer-specific neurons and astrocytes by radial glial cells during development of the cerebral cortex follows a precise temporal sequence, which is regulated by intrinsic and extrinsic factors. The molecular mechanisms controlling the timely generation of layer-specific neurons and astrocytes remain not fully understood. In this study, we show that the adhesion molecule contactin-associated protein (Caspr), which is involved in the maintenance of the polarized domains of myelinated axons, is essential for the timing of generation of neurons and astrocytes in the developing mouse cerebral cortex. Caspr is expressed by radial glial cells, which are neural progenitor cells that generate both neurons and astrocytes. Absence of Caspr in neural progenitor cells delays the production cortical neurons and induces precocious formation of cortical astrocytes, without affecting the numbers of progenitor cells. At the molecular level, Caspr cooperates with the intracellular domain of Notch to repress transcription of the Notch effector Hes1. Suppression of Notch signaling via a Hes1 shRNA rescues the abnormal neurogenesis and astrogenesis in Caspr-deficient mice. These findings establish Caspr as a novel key regulator that controls the temporal specification of cell fate in radial glial cells of the developing cerebral cortex through Notch signaling.
Introduction
The mammalian cerebral cortex is a well-organized structure containing layer-specific classes of neurons and glial cells, which are generated in a precise temporal order in that: deep-layer cortical neurons are generated first and upper-layer cortical neurons are born thereafter (Molyneaux et al. 2007; Greig et al. 2013; Kohwi and Doe 2013) . Astrocytes appear when neurogenesis is almost completed Kohwi and Doe 2013) . The layer-specific cortical neurons and glia arise from a small heterogeneous population of neural progenitor cells (NPCs) including radial glial cells (RGCs) in the ventricular zone (VZ) and intermediate progenitor cells (IPCs) in the subventricular zone (SVZ). RGCs produce both upper-layer neurons and deep-layer neurons directly or indirectly through IPCs (Franco et al. 2012; Kohwi and Doe 2013) . IPCs have been reported to generate exclusively upper-layer cortical neurons (Tarabykin et al. 2001; Cubelos et al. 2008) . However, some studies indicate that IPCs contribute more generally to neural cell generation in all cortical layers (Haubensak et al. 2004; Englund et al. 2005) . In contrast to RGCs, which generate both neurons and glia, IPCs generate only neurons (Noctor et al. 2004; Arnold et al. 2008) . Despite these differing reports, it is believed that both intrinsic and extrinsic cues regulate the sequential timing of NPC fate specification during cerebral cortical development, the molecular mechanisms of which are not fully understood.
Contactin-associated protein (Caspr), also known as paranodin or CNTNAP1, is a cell adhesion molecule belonging to the neurexin family (Bellen et al. 1998) , which also includes Caspr2, Caspr3, Caspr4 (Spiegel et al. 2002) , and Caspr5 (Traut et al. 2006; Weichenhan et al. 2008) . Caspr and Caspr2 are important for the formation and maintenance of axo-glial junctions of myelinated axons (Peles and Salzer 2000; Bhat et al. 2001; Gollan et al. 2003 Gollan et al. 2014 Poliak et al. 2003; Horresh et al. 2008; Horresh et al. 2010; Buttermore et al. 2013) . Novel functions of the Caspr family members have been identified recently in brain development, with Caspr2, Caspr4, and Caspr5 being risk factors in autism spectrum disorders (ASDs) (Mitchell 2011; Penagarikano et al. 2011; Anderson et al. 2012; O'Roak et al. 2012; Karayannis et al. 2014 ). Caspr2-deficient mice exhibit defects in cortical neuron migration, decreased numbers of GABAergic interneurons (Penagarikano et al. 2011) , runted dendritic arborizations, reduced spine densities (Anderson et al. 2012) , impaired GluA1 trafficking (Varea et al. 2015) , and autism-like behaviors (Penagarikano et al. 2011) . Caspr4 is expressed in NPCs and inhibits neurogenesis (Yin et al. 2015) . Caspr4-deficient mice show decreased neurotransmission in the GABAergic system and an elevated release of dopamine, resulting in abnormal sensory-motor gating and grooming endophenotypes (Karayannis et al. 2014 ). Similar to Caspr2, Caspr has been well studied in the formation and maintenance of polarized domains of myelinated axons (Peles and Salzer 2000; Bhat et al. 2001; Buttermore et al. 2013; Gordon et al. 2014) , but other functions of Caspr in the brain have not been investigated. However, some binding partners of Caspr have been identified, thereby allowing inferences about its functions in interactions with native prion protein and F3/contactin, which are involved in neurite outgrowth (Buttiglione et al. 1998; Chen et al. 2003; Santuccione et al. 2005; Zacharias and Rauch 2006; Pantera et al. 2009; Devanathan et al. 2010; Loubet et al. 2012) , neural proliferation, cortical neurogenesis (Bizzoca et al. 2003 (Bizzoca et al. , 2012 Steele et al. 2006; Santos et al. 2011; Xenaki et al. 2011; Puzzo et al. 2013; Prodromidou et al. 2014) , and synaptic plasticity (Caiati et al. 2013; Puzzo et al. 2015) . The combined observations indicate that Caspr is important for central nervous system functions more generally.
In the present study, we show that Caspr plays an essential role in regulating the timely sequential fate decision of NPCs in the development of the mouse cerebral cortex. We describe that Caspr is highly expressed in RGCs in the early neurogenic period, while it is mainly expressed in cortical neurons in the gliogenic period. Deficiency of Caspr in NPCs results in delayed production of both deep-and upper-layer cortical neurons as well as precocious formation of cortical astrocytes. We further show that Caspr suppresses Notch signaling by attenuating Hes1 transcription. Downregulation of Hes1 genes by a shRNA rescues the abnormal neurogenesis and gliogenesis of NPCs in Caspr-deficient mice, indicating that Caspr regulates the timing of cell fate specification of NPCs through Notch signaling during development of the mouse cerebral cortex.
Materials and Methods

Mice
Generation of Caspr-deficient mice (Caspr −/− mice) has been described (Gollan et al. 2003) . The mice used in this study were derived from heterozygous breeding pairs, and wild-type (Caspr +/+ ) littermate mice were used as controls. All mice in this study were handled according to the protocols approved by the Institutional Animal Care and Use Committee of Soochow University in accordance with international regulations.
Antibodies
Rabbit antibody against Caspr has been described (Devanathan et al. 2010) . The following commercially available antibodies were used: goat anti-Sox2 (1:80; Santa Cruz Biotechnology; sc-17320), rat anti-Nestin (1:80; Millipore; MAB353), mouse antiBrdU (1:100; Covance; MMS-139S), mouse anti-βIII-tubulin (Tuj1; 1:800; Sigma-Aldrich; T5076), rabbit anti-Pax6 (1:50; Covance; PRB-278P), rabbit anti-Ki67 (1:100; Thermo; PA5-19462), rabbit anti-active caspase-3 (1:100; R&D Systems; CFZ3410111), rabbit anti-Notch intracellular domain (NICD) (1:1000; Cell Signaling Technology; 4147), rabbit anti-Tbr1 (1:100; Abcam; ab3190), rabbit anti-Tbr2 (1:100; Abcam; ab23345), rabbit anti-Ctip2 (1:100; Abcam; ab28448), rabbit anti-Cux1 (1:100; Santa Cruz Biotechnology; sc-13024) and rabbit anti-BLBP (1:100; Millipore; ABN14). The secondary antibodies conjugated with Alexa fluorophores 488 or 555 were directed against the IgGs of the primary antibody species (1:500; Invitrogen).
Plasmids
Full-length mouse Caspr (amino acids 1-1385), the intracellular domain of Caspr (Caspr-ICD; amino acids 1306-1385), and the truncated Caspr (tCaspr) in which the intracellular domain of Caspr is deleted (amino acids 1-1305) were sub-cloned into the pCDF1-MSC2-EF1-copGFP vector, which encodes EGFP (Ma et al. 2008) . Primers were ATGCATCTCCGGCTCTTCTGCA (forward), TCATTCAG ACCTGGACTCCTCCAGG (reverse) for full-length Caspr; ATGATG CATCTCCGGCTCTTCTGCA (forward), TCAGAAGAGCACCAACATT CCCACC (reverse) for tCaspr; TATCTGCAAAATCATCGCTATAAGG (forward), TCATTCAGACCTGGACTCCTCCAGG (reverse) for Caspr-ICD. The identities of the constructs were confirmed by sequencing. The plasmids encoding Hes1, Notch intracellular domain (NICD), and LacZ (PGVB-Hes1, PcDNA3.1-NICD, and PCMV-LacZ, respectively) have been described (Hu et al. 2003) . Hes1 shRNA and its scrambled control (NC) were inserted into the PCMV G&NR-U6-shRNA vector, which encodes GFP (Niuen Biotechnology). The sequences of Hes1 shRNA were GAGGCGAAGGGCAAGAATAAA (called 487) or TCAACACGACACCGGACAAAC (called 488). The sequence of the normal control RNA (NC) was TTCTCCGAAC GTGTCACGT.
Culture of Neural Progenitor Cells
Neural progenitor cells were obtained from embryonic (E) day 14 mouse VZ (Ma et al. 2008 ) and maintained in DMEM/F12 (Gibco) containing B27 (Gibco), 20 ng/ml basic fibroblast growth factor (bFGF) (Peprotech), and 20 ng/ml epidermal growth factor (EGF) (Peprotech). For differentiation into astrocytes or neurons, NPCs were cultured in DMEM/F12 medium containing 0.5% fetal calf serum (Gibco) without EGF and bFGF for 3-5 days.
Transfection
Transfection of HEK293 cells was performed with lipofectamin 2000 according to the protocols provided by the manufacture (Invitrogen). Transfection of cultured NPCs was performed with the Nucelofector System (Lonza) according to the protocols provided in the Amaxa Nucleofector kit.
Immunocytochemistry and Immunochemistry
Immunostaining of cultured cells and brain sections was performed as described (Ma et al. 2008) . Quantification of the numbers of immunostained cells was performed also as described (Ma et al. 2008 
Measurement of Proliferation and Cell Cycle Exit
For pulse labeling of cells in the S phase, the pregnant mice were intraperitoneally injected with BrdU (50 mg/kg body weight) at different embryonic stages (E12, E14, and E18) and sacrificed 30 min (for proliferation) or 18 h (for cell cycle exit) after injection. 
Determination of Birthdates
Pregnant mice were intraperitoneally injected with 100 mg/kg body weight of BrdU at several embryonic stages (E11.5, E12.5, E13.5, E15.5, and E17.5). For analysis, the mice were sacrificed at E18.5 or postnatal day 0 (P0; for pregnant mice injected with BrdU at E17.5). The number of marker + cells from a single section was counted and expressed as a fraction of the total number of BrdU + cells per image as described (Seuntjens et al. 2009 ).
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
RNA was extracted from cultured cells or tissues using Trizol Reagent (Invitrogen). RT reactions were performed with the RevertAid First Strand cDNA Synthesis Kit (Promega). The primers for RT-PCRs were designed on the basis of the published mouse sequences. The primers for Caspr were: GAGGGAAGGGTGGATA AGG (forward), GGCACGATGCGGATGTAG (reverse); the primers for Hes1 were: GAGGTGACCCGCTTCCTGT (forward), CGAGGTCC CACTGTTGCTG (reverse); the primers for Hes5 were: CGCATCAA CAGCAGCATAGAG (forward), TGGAAGTGGTAAAGCAGCTTC (reverse); the primers for GAPDH were: CAAGGTCATCCATGA CAACTTTG (forward), GTCCACCACCCTGTTGCTGTAG (reverse).
Luciferase Reporter Assay
The Hes1-luciferase system has been described (Hu et al. 2003) . CHO cells were co-transfected with the PGVB-Hes1, PcDNA3.1-NICD, PCMV-LacZ plasmids, together with the PCDF-Caspr, PCDF-tCaspr, PCDF-CasprICD plasmids. The total amount of DNA per well was adjusted to be the same as the empty vector, which was used for mock transfection. Cells were lysed at 24-36 h after transfection and analyzed using the Steady-Glo Luciferase Assay Kit (Promega). Measurements were performed with a Microplate Reader (TECAN infinit M200 Pro).
Western Blot Analysis
Tissue and cell homogenates were lysed in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS, 50 mM Tris, pH, 8.0) and subjected to 8% SDS-PAGE. Protein concentrations were determined using the BCA Kit (Thermo).
Statistical Analysis
Data were collected from at least 3 (n ≥ 3) independent experiments or at least 3 pairs of Caspr −/− and Caspr +/+ litterrmates (n ≥ 3). Two-tailed Student's t test or One-Way ANOVA were performed using SPSS software. Values are presented as means ± SEM. Significance in differences was accepted at P<0.05 (*P<0.05, **P < 0.01, ***P < 0.001).
Results
Dynamic Expression of Caspr in RGCs and Cortical Neurons during Cortex Development
We first examined the expression of Caspr in the developing cortex during embryogenesis by co-immunostaining for Caspr and βIII-tubulin, a marker of neurons. During the neurogenic period, at E12 and E14, Caspr-immunoreativity was predominant in the VZ (Fig. 1A) , the niche where RGCs reside during embryonic stages. Double immunostaining for Caspr and Sox2 or Nestin as the markers for RGCs (Park et al. 2009; Hutton and Pevny 2011) confirmed that Caspr is expressed by RGCs in the VZ at E14 (Fig. 1B) . Expression levels of Caspr declined in the VZ from E16 onward. Caspr was then expressed predominantly by cortical neurons during the gliogenic period at E18 and P0 (Fig. 1A) . The specificity of the anti-Caspr antibody has been described (Devanathan et al. 2010) and was confirmed by the lack of immunofluorescence signal in histological sections from the cortex of Caspr −/− mice ( Supplementary Fig. 1 ). These results indicate that Caspr is expressed in RGCs in the early neurogenic period and expressed mainly in cortical neurons during the gliogenic period, suggesting that Caspr influences the generation of neurons and astrocytes in the developing cerebral cortex.
Deficiency in Caspr Delays the Generation of Cortical Neurons
We investigated whether deficiency in Caspr affects the number of various neuronal cell types in the cortex by immunostaining cortices for layer-specific markers such as Tbr1 (a marker of layer VI), Ctip2 (a marker of layer V), and Cux1 (a marker of layers II-IV) in Caspr −/− vs. Caspr +/+ mice at different embryonic stages.
Numbers of layer VI Tbr1 + cells were reduced in the cortex of Caspr −/− mice at E14 and E16, compared with Caspr +/+ littermates ( Fig Fig. 2A ,B, E), suggesting that the reduction in numbers of these layer-specific cortical neurons is not due to defects in migration. Apoptotic cells expressing activated caspase-3 were identical at E14 in Caspr +/+ versus Caspr −/− mice ( Supplementary Fig. 2 ), excluding the possibility that the reduced number of cortical neurons in Caspr −/− mice is due to cell death. Therefore, considering the fact that both deepand upper-layer cortical neurons in Caspr −/− mice exhibited decreased numbers in early neurogenesis, but recovered in numbers to levels comparable to those in Caspr +/+ mice at the end of neurogenesis, it is likely that cortical neuron generation is delayed during cortical development. To examine this possibility, cells were labeled with BrdU in their last S-phase at the time of BrdU injection at E11.5, E12.5, E13.5, E15.5, and E17.5. At E18.5 or P0 (for mice injected with BrdU at E17.5), embryos were collected, and the cortices were co-immunostained for BrdU and a layer-specific marker. The percentage of layer-specific cell types born at the time of injection (expressed as percentage of BrdU + marker + cells per total number of marker + cells) was analyzed. In the Caspr −/− cortex, less Tbr1 + neurons were found to be generated at E11.5 and E12.5 than in the Caspr +/+ cortex (Fig. 3A,D (Fig. 3C,D) . Thus, similar to deep-layer neurons, the generation of upper-layer neurons is also delayed by Caspr deficiency, indicating that Caspr is involved in the timing of cortical neurogenesis. Values represent means ± SEM. One-Way ANOVA. *P < 0.05; **P < 0.01; ***P < 0.001; NS: not significant.
Deficiency in Caspr Results in Precocious Astrocyte Formation
We further asked whether the generation of glial cells would be affected by Caspr deficiency. The timing in generation of astrocytes was examined by immunostaining for glial fibrillary acidic protein (GFAP) in the cortex at several stages (E12, E14, E16, and E18) (Fig. 4A) . Consistent with the observation that astrogenesis in the mouse cerebral cortex starts at E17.5 (Fan et al. 2005; Miller and Gauthier 2007) , GFAP + astrocytes were not detected in the VZ of Caspr +/+ mice until E18. By contrast, in Caspr −/− mice, GFAP + astrocytes appeared in the VZ at E14, the peak of the neurogenic period in Caspr +/+ mice (Fig. 4A,B) . At E18 (Fig. 4A,B) and P0
( Fig. 4C,D) , enhanced GFAP + signals were observed in the VZ of Caspr −/− (Fig. 4A,B) and Caspr +/− mice (Fig. 4C,D) , respectively. Increases numbers of GFAP + cells were also observed in the cortex and the corpus callosum of Caspr +/− mice at P7 ( Supplementary   Fig. 3A-D) . In contrast, neither GFAP + ( Supplementary Fig. 3E,F) nor S100β + cells ( Supplementary Fig. 3G ,H) exhibited differences in between Caspr +/− and Caspr +/+ cortex at P21. Consistently, elevated levels of GFAP were detected in Caspr −/− brain at E16, E18, and P0 by western blot analysis ( Supplementary Fig. 4A,B) . BrdU birthdating analysis showed more cells born at E17.5 being differentiated into GFAP + cells at P0 in the dorsal VZ of Caspr +/− mice ( Fig. 4C,E) . Moreover, numbers of cells expressing brain lipid binding protein (BLBP), which is expressed in RGCs and thereafter becomes restricted to astrocytes (Feng et al. 1994; Kurtz et al. 1994) , were increased in the dorsal VZ of E14 Caspr −/− mice (Fig. 4F,G) .
Some BLBP + cells in Caspr −/− mice lacked neurite-like processes extending from the ventricle to the marginal zone ( Fig. 4F ) and showed astrocyte-like morphologies (Nieto et al. 2001 ). These results indicate that deficiency of Caspr causes precocious astrogenesis.
Caspr Transiently Modulates Self-Renewal of Progenitor Cells in the Developing Cerebral Cortex
Since cell cycle length and/or exit affect production of neurons and astrocytes in the developing cerebral cortex (Cremisi et al. 2003; Hirai et al. 2012) , we investigated the timing of the cell cycle exit of NPCs in the VZ and SVZ 18 h after injection of BrdU by co-immunostainning for Ki67, which labels dividing cells, and BrdU, which marks the S-phase of the cell cycle. (Fig. 5H,I ) in E14 Caspr −/− mice. These results indicate that Caspr deficiency causes a transient increase in proliferation of RGCs at E14. We consider it unlikely that the delayed generation of neurons in the Caspr −/− cortex is caused by a transiently increased cell proliferation and decreased cell cycle exit at E14, since the delay in neurogenesis starts earlier, namely at E11.5 (Fig. 3A,D) .
Interestingly, the transiently increased cell proliferation and decreased cell cycle exit were not accompanied by an expansion of the RGC and IPC pools. The numbers of RGCs marked by Pax6 ( Supplementary Fig. 5A ,B) or Sox2 ( Supplementary Fig. 5C,D) and of IPCs marked by Tbr2 ( Supplementary Fig. 5E,F 
Caspr in NPCs Regulates Neurogenesis and Astrogenesis In Vitro
Since Caspr is expressed in both cortical neurons and RGCs in the early neurogenic period, we further investigated whether Caspr expressed in RGCs or in cortical neurons is responsible for regulating the timed generation of neurons and astrocytes. To this aim, NPCs from E14 littermate Caspr −/− and Caspr +/+ dorsal telecephalic ventricular walls were isolated and cultured in a serumfree system. Expression of Caspr was detected in Sox2 + NPCs (Fig. 6A-C) . Upon withdrawal of growth factors, these NPCs are known to sequentially differentiate into neurons and glia (Qian et al. 2000; Shen et al. 2006) . When being cultured under differentiation conditions in the absence of cytokines for 3-5 days, some NPCs differentiated into neurons and astrocytes, while some cells remained as progenitor cells, allowing to examine whether deletion of Caspr in NPCs would affect neurogenesis and gliogenesis in vitro ). Compared with Caspr +/+ cells, Caspr −/− NPCs differentiated less into neurons (Fig. 6D ,E) and more into astrocytes (Fig. 6F,G) . Thus, the in vivo phenotype was recapitulated in vitro, indicating that Caspr expressed in NPCs rather than in cortical neurons regulates the temporal specification of neurons and astrocytes in the developing cortex.
Caspr Represses Notch Signaling
We further searched for molecular mechanisms underlying regulation of the timing of neurogenesis and astrogenesis by Caspr. Caspr interacts with the adhesion molecule F3/contactin (Bonnon et al. 2003) , belonging to the immunoglobulin superfamily (Hu et al. 2003) . F3/contactin is a ligand of the receptor Notch (Hu et al. 2003) , which modulates the timed generation of neurons and astrocytes during cerebral cortex development (Bizzoca et al. 2012 ). Caspr4, a homolog of Caspr (Spiegel et al. 2002) , promotes neuronal differentiation through Lnx2 (Yin et al. 2015) , which also regulates Notch signaling (Nie et al. 2002; Camps et al. 2013) . In contrast to Caspr, however, which promotes neurogenesis, while inhibiting astrogenesis in the cerebral cortex, Notch signaling inhibits neurogenesis but promotes astrogenesis (Gaiano et al. 2000; Ge et al. 2002; Kamakura et al. 2004; Shimojo et al. 2008; Kageyama et al. 2009 ). These lines of evidence indicate a potential link between Caspr and Notch signaling. Consistent with this idea, the expression of the basic helix-loop-helix (bHLH) gene Hes1 (Fig. 7A ) rather than Hes5 (Fig. 7B) , both of which are effector genes of Notch signaling (Kageyama et al. , 2009 Imayoshi et al. 2010) , was increased in the Caspr −/− cortex. Upon binding to its ligand, Notch is cleaved by several secretases and releases its intracellular domain (NICD), which translocates to the nucleus to form a complex that enhances transcription of Hes1 (Honjo 1996; Kageyama et al. 2009 ). Deficiency in Caspr elevates levels of Hes1 mRNA, suggesting that Caspr may modulate Hes1 transcription. To test this idea, we cotransfected plasmids encoding a Hes1-luciferase reporter construct (Hu et al. 2003) and NICD together with a plasmid encoding full-length Caspr into CHO cells. Consistent with previous reports (Kageyama et al. 2009 ), NICD enhanced the transcriptional activity of Hes1 (Fig. 7D,E) . However, Caspr suppressed activation of Hes1 transcription by NICD (Fig. 7D ). Caspr is a type I transmembrane glycoprotein (Bellen et al. 1998 ), which contains in its (Einheber et al. 1997) . However, unlike other neurexins, the intracellular domain of Caspr lacks the carboxyl-terminal motif that binds to PDZ domains (Einheber et al. 1997) . In contrast, the intracellular domain of Caspr4 binds to Ligand of Numb protein-X2 (Lnx2) (Yin et al. 2015) , which enhances Notch signaling through degrading Numb (Nie et al. 2002) . Based on these observations, we analyzed which domain of Caspr is required for regulating Notch signaling. Similar to full-length Caspr, the truncated Caspr construct deleted in its intracellular domain (tCaspr, Fig. 7C ) attenuated the transcriptional activity of the Hes1 gene, while the intracellular domain of Caspr (Caspr-ICD, Fig. 7C ) did not influence the transcriptional activity of Hes1 (Fig. 7D ). In the absence of NICD, neither Caspr nor tCaspr/Caspr-ICD affected Hes1 transcriptional activity (Fig. 7E) , indicating that Caspr NPCs exhibited increased numbers of βIII-tubulin + cells (Fig. 8A,   B ), but reduced numbers of GFAP + cells (Fig. 8C,D) , at levels comparable to those of Caspr +/+ NPCs after being cultured under differentiation conditions for 3 days. These results indicate that downregulation of Hes1 rescues the abnormal neurogenesis and astrogenesis in Caspr −/− NPCs. We thus conclude that Caspr controls the timely sequential generation of neurons and astrocytes through regulation of Hes1 expression. Since Caspr attenuates activation of Hes1 transcription by NICD through its extracellular domain (Fig. 7C,D) , we examined whether Caspr modulates the differentiation of NPCs also through its extracellular domain. PCDF-EGFP plasmids expressing fulllength Caspr, Caspr-ICD, and tCaspr were transfected into Caspr −/− NPCs. Caspr-or tCaspr-transfected Caspr −/− NPCs differentiated more into βIII-tubulin + neurons, compared with the control EGFP-transfected Caspr −/− NPCs. Caspr-ICD did not enhance neurogenesis of Caspr −/− NPCs (Fig. 8E,F) . Moreover, overexpression of Caspr, tCaspr, rather than Caspr-ICD, increased neurogenesis in Caspr +/+ NPCs ( Supplementary Fig. 7 ). These results indicate that Caspr modulates differentiation of NPCs through regulating transcription of Hes1 via Caspr's extracellular domain. 
Discussion
The Caspr family members play essential roles in neuron-glia interactions (Peles and Salzer 2000; Bhat et al. 2001; Buttermore et al. 2013; Gordon et al. 2014 ). Caspr2 and Caspr4 are involved in development of the rodent cerebral cortex, contributing, when abnormal, to the etiology of ASDs (Penagarikano et al. 2011; Anderson et al. 2012; Karayannis et al. 2014; Varea et al. 2015) . We here characterize a novel role for Caspr as a factor switching neuron versus astrocyte fate decisions by developmentally modulating the timing in the generation of cortical neurons and astrocytes in the mouse cerebral cortex. Absence of Caspr causes delayed generation of neurons and precocious astrocyte formation, possibly resulting in perturbations in the relative ratios of these 2 cell types. Increased numbers of astrocytes caused by deficiency of Caspr starts from E16 and persists until P21, an essential developmental stage when neural circuits are established (Yang et al. 2013; Chung et al. 2015) . Consistently, precocious astrogenesis can lead to serious neurodevelopmental dysfunction as seen in RASopathy, which represents several developmental syndromes, such as Noonan syndrome (Tartaglia et al. 2001; Gauthier et al. 2007 ), neurofibromatosis-1 (Hegedus et al. 2007 ), Costello syndrome (Paquin et al. 2009 ), and cardiofaciocutaneous syndrome (Urosevic et al. 2011) . These syndromes share the phenotypes of mental impairment (Tidyman and Rauen 2009) . It is noteworthy in this context that astrocyte dysfunction may be a causative factor in the pathogenesis of ASDs and other psychiatric disorders (Ahlsen et al. 1993; Laurence and Fatemi 2005; Ballas et al. 2009; Lioy et al. 2011; Cao et al. 2012; Sloan and Barres 2014 (Cameron and Rakic 1991; Marshall et al. 2003; Kriegstein and Alvarez-Buylla 2009 ) and most of postnatal astrocytes are derived from local proliferation of differentiated astrocytes (Ge et al. 2012) . Thus, we suppose that Caspr only affects the astrocytic differentiation of RGCs, whereas it may play no function in local proliferation of postnatal astrocytes in the cerebral cortex. The inappropriate timing in neuron and astrocyte generation could be caused by a delayed cell cycle exit (Cremisi et al. 2003; Hirai et al. 2012) . A transiently decreased cell cycle exit in Caspr −/− NPCs was indeed observed at E14. Since the delay in generation of cortical neurons starts as early as E11.5, it is unlikely that the delayed generation of cortical neurons in Caspr −/− mice is due to a delayed cell cycle exit at E14. This transiently delayed cell cycle exit in Caspr −/− mice is accompanied by a transiently enhanced proliferation of RGCs, which fails to expand the NPC pool. Thus, it is possible that the transiently increased proliferation of RGCs compensates for impaired neurogenesis in the early neurogenic time period, which is, however, normalized in the late neurogenic period. Consistent with this idea is the observation that an extended generation of cortical neurons was detected in Caspr −/− mice. Furthermore, deletion of Caspr leads to a precocious formation of astrocytes as early as E14, being accompanied by an increased number of glial progenitor cells. Thus, we propose that a portion of RGCs with increased proliferative activity in E14 Caspr −/− mice may be glial progenitor cells, which differentiate into astrocytes. Interestingly, however, the sequential orderly generation of deep-and upper-layer cortical neurons is not affected by Caspr deficiency. Considering that molecular fate specification ensures proper birth order (Franco et al. 2012) , we propose that Caspr controls the neuronal versus glial fate decision rather than deep-versus upper-layer fate decision. In search for a molecular mechanism underlying these phenomena, we found that Caspr inhibits Notch signaling, which is a key regulator of the orderly progression of cell-type differentiation during cortical development (Nieto et al. 2001; Tanigaki et al. 2001; Gaiano and Fishell 2002; Schuurmans and Guillemot 2002; Kamakura et al. 2004; Miller and Gauthier 2007; Namihira et al. 2009; Piper et al. 2010; Chi et al. 2012) . Upon ligand binding, the receptor function of Notch depends on a series of proteolytic cleavage events that release its intracellular domain which translocates to the nucleus, where it forms a complex with a DNA binding protein, recombining binding protein . One-Way ANOVA (D,E). *P < 0.05; **P < 0.01; ***P < 0.001; NS: not significant.
suppressor of hairless (RBPJ) (Honjo 1996) , which represents a transcriptional activator that induces expression of Hes1 and Hes5 (Honjo 1996; Kageyama et al. 2008) . Hes1 or Hes5 which in turn inhibit neurogenesis and promote astrogliogenesis (Gaiano and Fishell 2002; Wu et al. 2003; Kageyama et al. 2008 Kageyama et al. , 2009 ) by antagonizing neurogenenic bHLH factors such as neurogenin 1/2 and mash1, which promote neurogenesis and repress gliogenesis (Nieto et al. 2001; Gaiano and Fishell 2002; Kageyama et al. 2008 Kageyama et al. , 2009 ). Hes1 or Hes5 are also involved in promoting activation of the JAK-STAT pathway (Nieto et al. 2001; Kamakura et al. 2004; Miller and Gauthier 2007) , which plays a central role in initiation of gliogenesis during development (Bonni et al. 1997; Miller and Gauthier 2007) . In addition to acting through Hes proteins, Notch signaling promotes astrogenesis also through other pathways. RBPJ binds directly to the gfap promoter and promotes transcription of the gfap gene, but only when the JAK-STAT pathway is coincidentally activated (Ge et al. 2002) . Notch signaling induces expression of nuclear factor 1, which binds to promoters driving astrocytic gene expression, resulting in demethylation of astrocyte-specific genes and thus enhanced astrogenesis (Namihira et al. 2009 ). We here show that reduction of Hes1 expression normalizes neurogenesis and astrogenesis in Caspr −/− NPCs, indicating that Caspr is an upstream regulator of Hes1 expression. This view is in agreement with the observation that Hes1 promotes astrogliogenesis through directly activating the JAK-STAT pathway and suppression of neurogenin expression inhibiting the JAK-STAT pathway (Nieto et al. 2001; Sun et al. 2001; Kamakura et al. 2004) . Indeed, we observed enhanced activation of the JAK-STAT pathway in the Caspr −/− cortex, as evidenced by enhanced phosphorylation of STAT3 in the Caspr −/− cortex ( Supplementary   Fig. 4C,D) . We thus propose that Caspr controls the timely sequential generation of neurons and astrocytes through Hes1. It is worth noting in this context that Notch signaling is not active uniformly in all cortical progenitor cells (Yun et al. 2002; Mason et al. 2005) . Although both RGCs and IPCs respond to Notch receptor activation, the essential mediator of Notch signaling, RBPJ, is only present in RGCs, but not in IPCs (Mizutani et al. 2007 ). Moreover, RGCs express higher levels of Notch receptors and Hes1/5 than IPCs (Mizutani et al. 2007) . Considering the fact that IPCs are predominantly neurogenic (Noctor et al. 2004; Arnold et al. 2008 ) and precocious maturation of astrocytes occurs when Caspr is deleted, we suggest that Caspr regulates the timing of cell fate specification of RGCs, but not of IPCs, through Notch signaling.
The present study has uncovered a novel function of Caspr in regulation of Hes1 transcription in that it acts in an NICD-dependent manner, independent of the intracellular domain of Caspr. In this respect, it is noteworthy that Caspr interacts with the cell adhesion molecule F3/contactin, a ligand of the Notch receptor, which regulates neurogenesis (Bizzoca et al. 2003; Puzzo et al. 2013) , progenitor cell proliferation (Xenaki et al. 2011) , and orderly progression of cortical development (Bizzoca et al. 2012) . Transgenic mice, which overexpress the L1 family member F3/contactin under control of a regulatory region of the human L1 family member TAX1 gene (Bizzoca et al. 2012) , show delayed neurogenesis, but enhanced astrogenesis, which is accompanied by activation of Notch signaling (Bizzoca et al. 2012 ), resulting in a phenotype similar to that of Caspr −/− mice.
Caspr interacts with F3/contactin through its extracellular domain in cis-interaction (Einheber et al. 1997 ) and regulates the cell surface expression of F3/contactin, which is accompanied by reduced glycosylation (Gollan et al. 2003) . Furthermore, Caspr inhibits the interaction between F3/contactin and the neurofascin isoform NF155, another L1 family member (Gollan et al. 2003) . It is therefore conceivable that Capsr attenuates Notch signaling through interfering with the interaction between F3/contactin and the Notch receptor. However, we found that in CHO cells which express the full-length Notch receptor at levels most likely too low to activate Hes1 transcription, Caspr fails to regulate Hes1 transcription. This phenomenon could be normalized by co-expression of NICD and Caspr, which suppresses Hes1 transcription, indicating that the regulatory function of Caspr in Hes1 transcription depends on NICD. Considering that Caspr regulates the processing and intracellular transport of F3/contactin (Gollan et al. 2003) , we propose that Caspr may inhibit the nuclear localization of NICD. It is interesting in this context that Caspr4 interacts with Ligand of Numb protein x2 (Lnx2) (Yin et al. 2015) , which degrades Numb, and thereby antagonizes Notch signaling (Nie et al. 2002) . Since Caspr4 and Caspr are structurally and functionally related, it is tempting to speculate that also Caspr interacts with Lnx2 as well. Interaction of Caspr with other proteins is also conceivable and remains to be investigated by assessing the functions of Caspr in the absence of F3/contactin and investigating the submolecular details underlying the interaction of Caspr with NICD. In summary, while Caspr is highly expressed in RGCs in the early neurogenic period, its expression declines in the gliogenic period but remains expressed in cortical neurons. Caspr expression in RGCs, rather than in cortical neurons, promotes neurogenesis while inhibiting astrogenesis by suppressing Notch signaling. Thus, in the early neurogenic period, Caspr expressed in RGCs promotes generation of cortical neurons while repressing that of cortical astrocytes. In the gliogenic period, when expression of Caspr in RGCs declines, astrogenesis is initiated (Fig. 9) , thereby attributing to Caspr a decisive role in the timing of cell fate decision in RGCs through suppression of Notch signaling during mammalian cerebral cortex development.
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